Brief: Sino Biopharmaceutical Says New Drug Application For TQB3909 Tablet Accepted By China's CDE
04/08/2026 13:23
BRIEF-Sino Biopharmaceutical Says New Drug Application For TQB3909 Tablet Accepted By China's CDE Aug 4 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK:
NEW DRUG APPLICATION FOR TQB3909 TABLET ACCEPTED BY CHINA'S CDE
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit